CTNNB1 and hepatocellular carcinoma: Around 26.7% of HCV-related HCCs harbor a CTNNB1 mutation, which is a much higher frequency than that observed in HBV-associated HCC (11.6%) or that observed in total non-virally-associated HCC (21.2%).